PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry
Publication
, Conference
Caron, M; Urs, NM; Peterson, SM; Snyder, JC
Published in: European Neuropsychopharmacology
October 2013
Duke Scholars
Published In
European Neuropsychopharmacology
DOI
ISSN
0924-977X
Publication Date
October 2013
Volume
23
Start / End Page
S108 / S109
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Caron, M., Urs, N. M., Peterson, S. M., & Snyder, J. C. (2013). PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry. In European Neuropsychopharmacology (Vol. 23, pp. S108–S109). Elsevier BV. https://doi.org/10.1016/s0924-977x(13)70120-2
Caron, M., N. M. Urs, S. M. Peterson, and J. C. Snyder. “PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry.” In European Neuropsychopharmacology, 23:S108–9. Elsevier BV, 2013. https://doi.org/10.1016/s0924-977x(13)70120-2.
Caron M, Urs NM, Peterson SM, Snyder JC. PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry. In: European Neuropsychopharmacology. Elsevier BV; 2013. p. S108–9.
Caron, M., et al. “PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry.” European Neuropsychopharmacology, vol. 23, Elsevier BV, 2013, pp. S108–09. Crossref, doi:10.1016/s0924-977x(13)70120-2.
Caron M, Urs NM, Peterson SM, Snyder JC. PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry. European Neuropsychopharmacology. Elsevier BV; 2013. p. S108–S109.
Published In
European Neuropsychopharmacology
DOI
ISSN
0924-977X
Publication Date
October 2013
Volume
23
Start / End Page
S108 / S109
Publisher
Elsevier BV
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences